Cited by Crossref (70)

  1. Hyeseung Lee, Sang Youl Rhee. Association between dietary circadian rhythms and metabolic dysfunction-associated steatotic liver disease risk. Life Cycle 2024;4
    https://doi.org/10.54724/lc.2024.e3
  2. Dachuan Jin, Shunqin Jin, Tao Zhou, Zhongfeng Cui, Baoqiang Guo, Guangming Li, Chunming Zhang. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis. Front. Public Health 2024;11
    https://doi.org/10.3389/fpubh.2023.1295165
  3. Nicolás Ortiz-López, Ana María Madrid, Larissa Aleman, Alejandra Zazueta, Gladys Smok, Lucía Valenzuela-Pérez, Jaime Poniachik, Caroll J. Beltrán. Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study. Front. Med. 2024;11
    https://doi.org/10.3389/fmed.2024.1376148
  4. Ritanna Curci, Caterina Bonfiglio, Isabella Franco, Claudia Beatrice Bagnato, Nicola Verrelli, Antonella Bianco. Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study. JCM 2024;13:3772
    https://doi.org/10.3390/jcm13133772
  5. Naveeda Nawaz, Saba Arif, Rehan Anwar, Adnan Riaz, Asima Ayyub, Rafia Javed. Association of Adiponectin and Oxidized HDL with ABO Blood Groups in Fatty Liver Patients. PJHS 2024:79
    https://doi.org/10.54393/pjhs.v5i07.1847
  6. Ming Yang, Shuai Liu, Chunye Zhang. The Related Metabolic Diseases and Treatments of Obesity. Healthcare 2022;10:1616
    https://doi.org/10.3390/healthcare10091616
  7. Stanislav Veselskyi, Andrii Pototskyi, Viktor Tomchuk, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2023;14:25
    https://doi.org/10.31548/veterinary3.2023.25
  8. Felipe A. Muñoz Rossi, Juanita Salazar Agudelo, Néstor Israel Quinapanta Castro, Sofía Z. Mosquera, Maria Clara Mejia Fajardo, Edgar Dario Mosquera López, Jonathan Dany Espitia Olarte, Maria Andrea Figueroa Medina, Edwin Zuniga Simancas, Luis Fernando Saldarriaga Osuna. Relationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Lipoprotein (a) and Other Biomarkers. 2024
    https://doi.org/10.7759/cureus.63019
  9. Masood Muhammad Karim, Amna Subhan Butt. Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment. World J Gastroenterol 2024;30:2371
    https://doi.org/10.3748/wjg.v30.i17.2371
  10. 禹 崔. Study on Association between SOCS1 rs243330 Polymorphisms and Non-Alcoholic Fatty Liver Disease. ACM 2024;14:352
    https://doi.org/10.12677/acm.2024.1451434
  11. Zheng Wang, Bohan Huang, Yixuan Ding, Feng Cao, Fei Li, Prof Fei Li. Association between life’s essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults. Arch Public Health 2024;82
    https://doi.org/10.1186/s13690-024-01331-3
  12. Helaina E. Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, Jean A. Welsh, Miriam B. Vos. The Impact and Burden of Dietary Sugars on the Liver. 2023;7
    https://doi.org/10.1097/HC9.0000000000000297
  13. Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim. Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study. Metabolism 2024;152:155789
    https://doi.org/10.1016/j.metabol.2024.155789
  14. Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications. Front. Endocrinol. 2022;13
    https://doi.org/10.3389/fendo.2022.1035159
  15. Hardika S Vegda, Bhavin Patel, Gaurav A Girdhar, Mohd. Shabankhan H Pathan, Rahnuma Ahmad, Mainul Haque, Susmita Sinha, Santosh Kumar. Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship. 2024
    https://doi.org/10.7759/cureus.63775
  16. Gabriela Wünsch Lopes, Scheine Leite Canhada, Rodrigo Citton Padilha dos Reis, Maria de Fátima Haueisen Sander Diniz, Alessandra Carvalho Goulart, Luciana Costa Faria, Rosane Harter Griep, Hugo Perazzo, Bruce Bartholow Duncan, Maria Inês Schmidt. Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study. Cad. Saúde Pública 2024;40
    https://doi.org/10.1590/0102-311xen009924
  17. Gyu Bae Lee, Youn Huh, Sang Hyun Lee, Byoungduck Han, Yang-Hyun Kim, Do-Hoon Kim, Seon Mee Kim, Youn Seon Choi, Kyung Hwan Cho, Ga Eun Nam. Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study. World J Gastroenterol 2023;29:5962
    https://doi.org/10.3748/wjg.v29.i45.5962
  18. Laisha Yan, Xiaoyan Hu, Shanshan Wu, Can Cui, Shunying Zhao. Association between the cardiometabolic index and NAFLD and fibrosis. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-64034-3
  19. Sung Woo Choi, Wonjun Cho, Heeseung Oh, A.M. Abd El-Aty, Soon Auck Hong, Mineui Hong, Ji Hoon Jeong, Tae Woo Jung. Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress. Biochemical Pharmacology 2023;217:115815
    https://doi.org/10.1016/j.bcp.2023.115815
  20. Muthukumaran Jayachandran, Shen Qu. Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies. Rev Endocr Metab Disord 2023;24:1189
    https://doi.org/10.1007/s11154-023-09843-z
  21. Basile Njei, Eri Osta, Nelvis Njei, Yazan A. Al-Ajlouni, Joseph K. Lim. An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-59183-4
  22. Caterina Bonfiglio, Rossella Tatoli, Rossella Donghia, Davide Guido, Gianluigi Giannelli. Exploratory Role of Flavonoids on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a South Italian Cohort. Antioxidants 2024;13:1286
    https://doi.org/10.3390/antiox13111286
  23. Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oh. Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Obesity & Metabolic Syndrome 2023;32:289
    https://doi.org/10.7570/jomes23054
  24. Scott L. Friedman. Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome. Diabetes Metab J 2024;48:161
    https://doi.org/10.4093/dmj.2023.0240
  25. Su-Min Jeong, Jin-Hyung Jung, Ye Seul Yang, Wonsock Kim, In Young Cho, You-Bin Lee, Kye-Yeung Park, Ga Eun Nam, Kyungdo Han. 2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021. Journal of Obesity & Metabolic Syndrome 2024;33:27
    https://doi.org/10.7570/jomes24012
  26. Nam-Hun Lee, Seok-Ju Jeong, Jing-Hua Wang, Yu-Jin Choi, Hyeon-Muk Oh, Jung-Hyo Cho, Yo-Chan Ahn, Chang-Gue Son. The Clinical Diagnosis-Based Nationwide Epidemiology of Metabolic Dysfunction-Associated Liver Disease in Korea. JCM 2023;12:7634
    https://doi.org/10.3390/jcm12247634
  27. Miao Zhang, Keting Dong, Qian Du, Jiaojiao Xu, Xue Bai, Lei Chen, Jianhong Yang. Chemically synthesized osteocalcin alleviates NAFLD via the AMPK-FOXO1/BCL6-CD36 pathway. J Transl Med 2024;22
    https://doi.org/10.1186/s12967-024-05592-y
  28. Seung-Ju Hwang, Yu-Jin Choi, Jing-Hua Wang, Chang-Gue Son. Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model. Biomedicine & Pharmacotherapy 2024;172:116250
    https://doi.org/10.1016/j.biopha.2024.116250
  29. Xuangao Wu, Ting Zhang, Sunmin Park. Dietary quality, perceived health, and psychological status as key risk factors for newly developed metabolic dysfunction–associated steatotic liver disease in a longitudinal study. Nutrition 2025;130:112604
    https://doi.org/10.1016/j.nut.2024.112604
  30. Hung-Tsung Wu, Chin-Shiang Tsai, Ting-Hsing Chao, Horng-Yih Ou, Liang-Miin Tsai. A Novel Antioxidant, Hydrogen-Rich Coral Calcium Alters Gut Microbiome and Bile Acid Synthesis to Improve Methionine-and-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease. Antioxidants 2024;13:746
    https://doi.org/10.3390/antiox13060746
  31. Stefan Mauss, Jack T. Stapleton, David L. Thomas. Steatotic liver disease progression in persons with HIV: weighting for answers. 2024;38:1432
    https://doi.org/10.1097/QAD.0000000000003893
  32. Sven H. Loosen, Karel Kostev, Tom Luedde, Christoph Roderburg. Infectious mononucleosis is associated with an increased incidence of NAFLD. Eur J Clin Investigation 2023;53
    https://doi.org/10.1111/eci.13911
  33. Xuefeng Ren, Jinghui Zhang, Hongwei Xiang, Qing Zhou, Shaoqin Ge, Huiling Xue. Regulation of PPARγ/RXRα signaling pathway by Huaji Jianpi decoction in the prevention and treatment of simple obesity. Chinese Journal of Analytical Chemistry 2024:100466
    https://doi.org/10.1016/j.cjac.2024.100466
  34. Seong-Uk Baek, Taeyeon Kim, Yu-Min Lee, Jong-Uk Won, Jin-Ha Yoon. Association between Dietary Quality and Non-Alcoholic Fatty Liver Disease in Korean Adults: A Nationwide, Population-Based Study Using the Korean Healthy Eating Index (2013–2021). Nutrients 2024;16:1516
    https://doi.org/10.3390/nu16101516
  35. Devi Basumatary, Santanu Das, M. Bidyarani Devi, G. Shalini Devi, Pranamika Sarma, Ashis K. Mukherjee, Mojibur R. Khan, Jagat C. Borah. Garcinol enriched fraction of Garcinia morella (Gaertn.) Desr. fruit rind improves gut health and reduces the risk of nonalcoholic fatty liver disease by regulating PCK1/ACC/SREBP1/FASn pathway in a mouse model. Food Research International 2024;197:115285
    https://doi.org/10.1016/j.foodres.2024.115285
  36. Subhajit Ghosh, Ritobhas Datta, Subarna Thakur. Network-based meta-analysis of gene expression reveals novel prognostic biomarkers for the progression of hepatocellular carcinoma from non-alcoholic fatty liver disease. Human Gene 2024;42:201357
    https://doi.org/10.1016/j.humgen.2024.201357
  37. Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, Jun-Hyuk Lee, Yu-Jin Kwon. Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study. Digestive and Liver Disease 2024;56:1529
    https://doi.org/10.1016/j.dld.2024.01.200
  38. Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, Hitesh Chopra, Madhav Singla, Smriti, Saurabh Gupta, Rohit Sharma. Molecular targets and therapeutic potential of baicalein: a review. dti 2024;18:30
    https://doi.org/10.33393/dti.2024.2707
  39. Wah-Kheong Chan, Kee-Huat Chuah, Ruveena Bhavani Rajaram, Lee-Ling Lim, Jeyakantha Ratnasingam, Shireene Ratna Vethakkan. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. Journal of Obesity & Metabolic Syndrome 2023;32:197
    https://doi.org/10.7570/jomes23052
  40. Jacobus Albertus Auwyang, Esti Widiasih. Can liver enzyme profile be a predictor of NAFLD in type-2 diabetes mellitus (T2DM) patients? ‎. J Adv Pharm Educ Res 2024;14:8
    https://doi.org/10.51847/bkCKYeFzHB
  41. Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, Vikas Tiwari, Kajal Deshmukh, Jagdish Kumar Balani, Samhita Chakraborty, Md Jahangir Alam, Sanjay K. Banerjee. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation. Cellular Signalling 2024;121:111299
    https://doi.org/10.1016/j.cellsig.2024.111299
  42. Chun-Hung Chiu, Ming-Yao Chen, Jun-Jie Lieu, Chin-Chu Chen, Chun-Chao Chang, Charng-Cherng Chyau, Robert Y. Peng. Inhibitory Effect of Styrylpyrone Extract of Phellinus linteus on Hepatic Steatosis in HepG2 Cells. IJMS 2023;24:3672
    https://doi.org/10.3390/ijms24043672
  43. José Alfonso Cortés Rubio, Diego Martín Acicoya, Marta Candela Fernández, Elena Alcanda Renquel, Adriana Vañó Garrido-Arroquia, M Cortés Costa. Validación del test FLI (Fatty Liver Index) para el diagnóstico de esteatosis hepática en pacientes con obesidad y/o diabetes mellitus para su utilización en Atención Primaria. Estudio FLIAP. Rev Clín Med Fam 2023:325
    https://doi.org/10.55783/rcmf.160404
  44. Sasha A. S. Kjeldsen, Mikkel P. Werge, Josephine Grandt, Michael M. Richter, Mira Thing, Liv E. Hetland, Elias B. Rashu, Anne-Sofie H. Jensen, Marie Winther-Sørensen, Jesper Sloth Kellemann, Jens J. Holst, Anders E. Junker, Reza R. Serizawa, Mogens Vyberg, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024;327:G558
    https://doi.org/10.1152/ajpgi.00147.2024
  45. Maha Hoteit, Myriam Dagher, Nikolaos Tzenios, Najat Al Kaaki, Ghadir Rkein, Abdul Rahman Chahine, Yonna Sacre, Samer Hotayt, Rami Matar, Mahmoud Hallal, Micheal Maitar, Bilal Hotayt. Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study. Healthcare 2024;12:591
    https://doi.org/10.3390/healthcare12050591
  46. Eun Kyung Choe, Hae Yeon Kang. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-56796-7
  47. Annette Brandt, Florian Kopp. Long Noncoding RNAs in Diet-Induced Metabolic Diseases. IJMS 2024;25:5678
    https://doi.org/10.3390/ijms25115678
  48. Ayoub Basham, Shideh Rafati, Saeed Hosseini Teshnizi, Ebrahim Evazi, Fereshteh Khozeimeh, Seyed Moayed Alavian, Farkhondeh Razmpour. Application of the Chinese Visceral Adiposity Index in the Diagnosis of Hepatic Steatosis and Liver Fibrosis: A Cross-Sectional Study. Hepat Mon 2024;23
    https://doi.org/10.5812/hepatmon-150455
  49. Alla Kuznetsova, Anastasiya Dolgushina, Albina Savochkina, Lubov Pykhova, Veronika Sumerkina, Anna Selyanina, Yana Kudrinskaya, Vadim Genkel. Liver Stiffness Is Associated with the Burden of Carotid and Systemic Atherosclerosis in an Unorganized Cohort of Patients 40–64 Years Old. Diagnostics 2022;12:2336
    https://doi.org/10.3390/diagnostics12102336
  50. Sooyeon Oh, Jooho Lee, Sukyung Chun, Ja-Eun Choi, Mi Na Kim, Young Eun Chon, Yeonjung Ha, Seong-Gyu Hwang, Sang-Woon Choi, Kyung-Won Hong. Interaction between the PNPLA3 Gene and Nutritional Factors on NAFLD Development: The Korean Genome and Epidemiology Study. Nutrients 2022;15:152
    https://doi.org/10.3390/nu15010152
  51. Rossella Maresca, Irene Mignini, Simone Varca, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together. IJMS 2024;25:3278
    https://doi.org/10.3390/ijms25063278
  52. Nikola Mitrović, Nataša Nikolić, Ana Filipović, Ankica Vujović, Uroš Karić, Miloš Šabanović, Ivana Milošević. The impact of chronic viral hepatitis on COVID-19: Clinical course and risk factors for poor outcome. Medicinska istraživanja 2024;57:65
    https://doi.org/10.5937/medi57-48691
  53. Ioanna Aggeletopoulou, Efthymios P. Tsounis, Christos Triantos. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights. IJMS 2024;25:4901
    https://doi.org/10.3390/ijms25094901
  54. Sophia M. Schmitz, Sebastian Storms, Alexander Koch, Christine Stier, Andreas Kroh, Karl P. Rheinwalt, Sandra Schipper, Karim Hamesch, Tom F. Ulmer, Ulf P. Neumann, Patrick H. Alizai. Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery. Biomedicines 2023;11:1595
    https://doi.org/10.3390/biomedicines11061595
  55. Maryam Khalilinejad, Mandana Gholami, Fereshteh Shahmohammadi Dermani, Farshad Ghazalian. The Effect of Four Weeks of Swimming Training on Insulin Resistance and Hepatokines in Rats with PCOS. J Health Rep Technol 2024;10
    https://doi.org/10.5812/jhrt-140930
  56. Marcin Kosmalski, Józef Drzewoski, Izabela Szymczak-Pajor, Andrzej Zieleniak, Melania Mikołajczyk-Solińska, Jacek Kasznicki, Agnieszka Śliwińska. Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD). Biomedicines 2022;10:2253
    https://doi.org/10.3390/biomedicines10092253
  57. Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Mohan Pandey, Neena Bhatia. Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study. Human Nutrition & Metabolism 2023;32:200188
    https://doi.org/10.1016/j.hnm.2023.200188
  58. Chawon Yun, Sou Hyun Kim, Doyoung Kwon, Mi Ran Byun, Ki Wung Chung, Jaewon Lee, Young-Suk Jung. Doxorubicin Attenuates Free Fatty Acid-Induced Lipid Accumulation via Stimulation of p53 in HepG2 Cells. Biomol Ther (Seoul) 2024;32:94
    https://doi.org/10.4062/biomolther.2023.200
  59. Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park. Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017. Diabetes Metab J 2023;47:347
    https://doi.org/10.4093/dmj.2022.0444
  60. Da-Hye Son, Jee Hye Han, Jun-Hyuk Lee. Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 2023;32:214
    https://doi.org/10.7570/jomes22066
  61. Julia A. Golubeva, Anna F. Sheptulina, Anastasia Yu. Elkina, Ekaterina O. Liusina, Anton R. Kiselev, Oxana M. Drapkina. Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?. Biomedicines 2023;11:2465
    https://doi.org/10.3390/biomedicines11092465
  62. Sung-Bum Lee, Ja-Eun Choi, Kyung-Won Hong, Dong-Hyuk Jung. Genetic Variants Linked to Myocardial Infarction in Individuals with Non-Alcoholic Fatty Liver Disease and Their Potential Interaction with Dietary Patterns. Nutrients 2024;16:602
    https://doi.org/10.3390/nu16050602
  63. Marcelo Hatto, Victor Kenzo Ivano, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim, Everton Cazzo. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery. OBES SURG 2023;33:1580
    https://doi.org/10.1007/s11695-023-06568-5
  64. Soheila Borji, Hadi Sabat Sani, Saharnaz Ghorbani, Mohammad Soltani, Vahid Mohammadi, Reza Elahi. The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size. J Ultrasound 2024
    https://doi.org/10.1007/s40477-024-00965-x
  65. Frankie Chi Fat Ko, Sheng Yan, Ka Wai Lee, Sze Kwan Lam, James Chung Man Ho. Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy. Biomolecules 2023;13:902
    https://doi.org/10.3390/biom13060902
  66. Ester Díez-Sainz, Paula Aranaz, Ez-Zoubir Amri, José I. Riezu-Boj, Silvia Lorente-Cebrián, Fermín I. Milagro. Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis. IJMS 2024;25:1721
    https://doi.org/10.3390/ijms25031721
  67. Qianying Liu, Peiwen Li, Jinglan Ma, Jiazhen Zhang, Weiya Li, Yuenan Liu, Lu Liu, Sen Liang, Meian He. Arsenic exposure at environmentally relevant levels induced metabolic toxicity in development mice: Mechanistic insights from integrated transcriptome and metabolome. Environment International 2024;190:108819
    https://doi.org/10.1016/j.envint.2024.108819
  68. Ruxianguli Aimuzi, Zhilan Xie, Yimin Qu, Kai Luo, Yu Jiang. Proteomic signatures of ambient air pollution and risk of non-alcoholic fatty liver disease: A prospective cohort study in the UK Biobank. Science of The Total Environment 2024;957:177529
    https://doi.org/10.1016/j.scitotenv.2024.177529
  69. Andrea Ferrigno, Marta Cagna, Oriana Bosco, Michelangelo Trucchi, Clarissa Berardo, Ferdinando Nicoletti, Mariapia Vairetti, Laura G. Di Pasqua. MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice. IJMS 2023;24:6076
    https://doi.org/10.3390/ijms24076076
  70. Masoumeh Khalifeh, Raul D. Santos, Reza Kazemi Oskuee, Ali Badiee, Seyed Hamid Aghaee-Bakhtiari, Amirhossein Sahebkar. A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis. Progress in Lipid Research 2023;89:101197
    https://doi.org/10.1016/j.plipres.2022.101197